Recombinant GPIIb/IIIa (Abciximab Biosimilar) antibody

Catalog No. ABIN7072232

The Human Monoclonal anti-GPIIb/IIIa (Abciximab Biosimilar) antibody is suitable to detect GPIIb/IIIa (Abciximab Biosimilar) in samples from Human. It has been validated for BR and FACS.

Quick Overview for Recombinant GPIIb/IIIa (Abciximab Biosimilar) antibody (ABIN7072232)

Target: GPIIb/IIIa (Abciximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Blocking Reagent (BR), Flow Cytometry (FACS)

Clone: 7E3

Product Details

Purpose: Anti-CD41 [7E3 (Abciximab)], Human IgG1, kappa

Specificity: Recognises human CD41.

Characteristics:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Immunogen: CD41 is the integrin alpha chain 2b forming a fibrinogen receptor in heterodimeric complex with beta 3.

Isotype: IgG1 kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Restrictions: For Research Use only

Handling

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details

Target: GPIIb/IIIa (Abciximab Biosimilar)

Target Type: Biosimilar

Background: Integrin alpha-IIb, Integrin alpha-2b, ITGA2B, platelet glycoprotein IIb of IIb/IIIa complex

UniProt: P08514